Arkansas State Medical Board.
Arkansas State Medical Board.
Why It Matters
Relevant to healthcare professionals operating in AR.
Welcome to your daily briefing on healthcare developments in Arkansas. Today we're covering 8 key stories including updates on arkansas healthcare headlines, background & context. Let's dive in.
5 stories
Arkansas State Medical Board.
Relevant to healthcare professionals operating in AR.
Health Access Publications.
Relevant to healthcare professionals operating in AR.
Verify a medical practitioner’s license status by selecting license number or last name. Enter the information and press the “Verify” button to view the results.
Relevant to healthcare professionals operating in AR.
The Arkansas Department of Health (ADH) promotes and protects the health of Arkansans with the licensure and regulation of health facility services in Arkansas. ADH is the state survey agency for the Centers for Medicare & Medicaid….
Relevant to healthcare professionals operating in AR.
(missing).
Relevant to healthcare professionals operating in AR.
Reach healthcare professionals
3 stories
The MIPS cost performance category is calculated retrospectively by CMS using attributed Medicare claims; clinicians cannot directly affect what is attributed. The two attribution methods (TPCC and MSPB) capture different beneficiary cohorts. Practices that try to "manage" cost without understanding which patients are attributed to which clinician typically waste effort.
Cost is now 30% of the MIPS final score — the largest single category. Misunderstanding attribution is the leading cause of unfavorable payment adjustments in the next cycle.
The No Surprises Act good-faith-estimate requirement applies to all licensed providers offering services to self-pay or uninsured patients — not just hospitals or large groups. The estimate must be provided within timeframes that vary by how far in advance the appointment is scheduled.
Patient-provider dispute resolution under NSA typically defaults to the patient when the practice cannot produce a timely good-faith estimate. The penalty is the full disputed amount being struck.
Covered entities must annually recertify their 340B eligibility through HRSA. Missing the recertification window pushes the entity to inactive status, which means immediate loss of 340B pricing and potentially diversion violations on previously dispensed drugs. Reinstatement requires a new application.
The discount value of 340B pricing for a covered entity often exceeds six figures annually. Letting the recertification lapse for paperwork reasons is one of the most expensive administrative errors in the regulation.
Get Arkansas healthcare intelligence delivered to your inbox every morning.
Subscribe FreeView all past issues
Feature your brand across the U.S., Canada, and select international markets and 10 industry verticals.
Become a National Partner